MEFOXIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mefoxin, and what generic alternatives are available?
Mefoxin is a drug marketed by Norvium Bioscience and Merck and is included in four NDAs.
The generic ingredient in MEFOXIN is cefoxitin sodium. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MEFOXIN?
- What are the global sales for MEFOXIN?
- What is Average Wholesale Price for MEFOXIN?
Summary for MEFOXIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 63 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,774 |
| DailyMed Link: | MEFOXIN at DailyMed |
Recent Clinical Trials for MEFOXIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of KwaZulu | N/A |
| Bristol-Myers Squibb | N/A |
US Patents and Regulatory Information for MEFOXIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norvium Bioscience | MEFOXIN | cefoxitin sodium | INJECTABLE;INJECTION | 062757-001 | Jan 8, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER | cefoxitin sodium | INJECTABLE;INJECTION | 050581-004 | Sep 20, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Norvium Bioscience | MEFOXIN | cefoxitin sodium | INJECTABLE;INJECTION | 050517-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Norvium Bioscience | MEFOXIN IN PLASTIC CONTAINER | cefoxitin sodium | INJECTABLE;INJECTION | 063182-001 | Jan 25, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
